ORBIMED ADVISORS LLC – Mersana Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$60.91M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+46.32%
quarter
Mersana Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 19.28M | $6.76 | 9.01M | |
| Q2 2022 | share | Increase | +88.17% | 4.22M shares | 22.52M | $4.62 | 9.01M |
| Q1 2022 | share | Increase | +65.77% | 1.90M shares | 1.13M | $3.99 | 4.78M |
| Q4 2021 | share | 0.00% | 0 shares | -9.27M | $6.4 | 2.88M | |
| Q3 2021 | share | Increase | +3.16% | 88.6K shares | -10.78M | $9.43 | 2.88M |
| Q2 2021 | share | Increase | +47.97% | 907.74K shares | 7.40M | $13.58 | 2.80M |
| Q1 2021 | share | Increase | +144.72% | 1.11M shares | 10.04M | $16.18 | 1.89M |
| Q4 2020 | share | Decrease | -41.80% | -555.50K shares | -4.16M | $26.61 | 773.34K |
| Q3 2020 | share | Decrease | -30.43% | -581.15K shares | -19.95M | $18.62 | 1.32M |
| Q2 2020 | share | Increase | +41.83% | 563.28K shares | 36.84M | $23.4 | 1.91M |
| Q1 2020 | share | Decrease | -35.05% | -726.59K shares | -4.02M | $5.83 | 1.34M |
| Q4 2019 | share | Increase | +9.63% | 182.2K shares | 8.89M | $5.73 | 2.07M |
| Q3 2019 | share | 0.00% | 0 shares | -4.67M | $1.58 | 1.89M | |
| Q2 2019 | share | 0.00% | 0 shares | -2.28M | $4.05 | 1.89M | |
| Q1 2019 | share | Increase | 0.00% | 1.89M shares | 9.94M | $5.26 | 1.89M |